Skip to main content
Clinical Trials/NCT03415061
NCT03415061
Not yet recruiting
Not Applicable

Does Intranasal Insulin Administration Reduce the Incidence of Cognitive Dysfunction After Cardiac Surgery?

Hiroaki Sato, MD., PhD.1 site in 1 country494 target enrollmentNovember 1, 2021

Overview

Phase
Not Applicable
Intervention
Regular Insulin, Human 100 UNT/ML
Conditions
Delirium
Sponsor
Hiroaki Sato, MD., PhD.
Enrollment
494
Locations
1
Primary Endpoint
Confusion Assessment method for the ICU
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

Decline in cognitive function after surgery occurs most commonly in older patients and patients undergoing major surgeries, such as heart surgery. Postoperative Cognitive Dysfunction (POCD) may last a prolonged period of time while Postoperative Delirium (POD) is a more acute disturbance in attention, awareness and cognition. The cause of POCD and POD are not fully understood, however some of the pathophysiology of POCD is similar to that of Alzheimer's disease (AD).

Insulin given intravenously during heart surgery has been shown to preserve short and long-term memory function after the operation. Clinical trials further demonstrated that insulin given via the nose (intranasal) improves memory performance of patients with AD or cognitive impairment suggests that intranasal insulin also could be a therapeutic option for POCD and POD.

This study is designed to examine the effect intranasal insulin on POCD and POD. The goal is to investigate whether administration of intranasal insulin during and after heart surgery improves cognitive function postoperatively.

Registry
clinicaltrials.gov
Start Date
November 1, 2021
End Date
November 30, 2024
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Hiroaki Sato, MD., PhD.
Responsible Party
Sponsor Investigator
Principal Investigator

Hiroaki Sato, MD., PhD.

Assistant Professor

McGill University Health Centre/Research Institute of the McGill University Health Centre

Eligibility Criteria

Inclusion Criteria

  • elective open heart surgery requiring cardiopulmonary bypass

Exclusion Criteria

  • inability to provide informed consent
  • allergy to insulin
  • pregnancy
  • mother tongue other than English or French
  • visual or hearing impairment interfering with the ability to complete cognitive tests.

Arms & Interventions

Intranasal Insulin 40 IU

40 IU of Humulin-R via nose Before surgery and everyday after surgery up to postoperative day 7

Intervention: Regular Insulin, Human 100 UNT/ML

Intranasal Normal Saline

Normal Saline via nose Before surgery and everyday after surgery up to postoperative day 7

Intervention: Normal Saline Flush, 0.9% Injectable Solution

Outcomes

Primary Outcomes

Confusion Assessment method for the ICU

Time Frame: Up to 7 days after surgery

Postoperative Delirium is assessment

Rey Auditory Verbal Leaning

Time Frame: up to 12 month

Episodic Memory Lowest score: 0 Highest Score: 15

Rey-Osterrieth Complex Figure Test

Time Frame: up to 12 month

Episodic Memory Lowest score: 0 Highest Score: 8

Secondary Outcomes

  • Stroop Test(up to 12 month)
  • Trail Making Test(up to 12 month)
  • Tower of London test(up to 12 month)
  • Symbol Digit Modalities Test(up to 12 month)
  • Boston Naming Test(up to 12 month)
  • Clock Drawing Test(up to 12 month)

Study Sites (1)

Loading locations...

Similar Trials